<ѻý>ADA 2022: Racial Residential Segregation, DKA During COVID, and Moreѻý> Noteworthy research presented at the American Diabetes Association annual meeting Jun 08, 2022
<ѻý>Concerning Trends in Vision Impairment for Adults With Diabetes?ѻý> Steady decreases in the prevalence of patients with eye problems may be over Jun 07, 2022
<ѻý>Tirzepatide Reduced Albuminuria in T2D Patients With Heart Riskѻý> Subanalysis of SURPASS-4 trial compared the GLP-1/GIP agonist against insulin glargine Jun 06, 2022
<ѻý>Is Diabetes a Risk Factor for Long COVID? Possibly.ѻý> Mixed results in seven-study scoping review Jun 05, 2022
<ѻý>Dulaglutide Improves HbA1c for Youth With Type 2 Diabetesѻý> Safety profile consistent with that reported in adults Jun 05, 2022
<ѻý>Tirzepatide Serves Up Major Weight-Loss Win in Patients With Obesityѻý> SURMOUNT-1 trial tested GIP/GLP-1 receptor agonist in people without diabetes Jun 05, 2022
<ѻý>Sugar-Sweetened Beverage Taxes Cut Sales by 15%ѻý> However, evidence of tax undershifting was apparent Jun 01, 2022
<ѻý>No Cardioprotection Seen With Long-Term Metformin or Lifestyle Interventionѻý> Both approaches "highly effective" in T2D, but not for preventing CV disease, expert says May 24, 2022
<ѻý>SGLT2 Inhibitors a Better First Drug in Type 2 Diabetes Than Metformin?ѻý> Observational study suggests some cardiovascular benefit May 23, 2022
<ѻý>Diabetic Pain Relief Lasts With High Frequency Spinal Cord Stimulationѻý> Trial followed patients with Senza System for 18 months May 16, 2022
<ѻý>Patients With Type 2 Diabetes and CKD Face Poor COVID Outcomesѻý> Severity of kidney disease ups risk of ICU time, in-hospital mortality, and more May 15, 2022
<ѻý>First GLP-1/GIP Receptor Agonist OK'd for Type 2 Diabetesѻý> Injectable tirzepatide lands approval as an adjunct to diet and exercise May 13, 2022
<ѻý>GIP/GLP-1 Receptor Agonist Slashes Body Weight by More Than 20%ѻý> "Impressive" topline results from trial in adults with overweight, obesity without diabetes May 02, 2022
<ѻý>More Evidence That Fenofibrate Slows Diabetic Eye Diseaseѻý> Significant decline in progression to vision-threatening status, proliferative retinopathy Apr 26, 2022
<ѻý>How Often Does Prediabetes in Seniors Escalate to Full-Blown Disease?ѻý> Study finds estimated annual progression rate to diabetes of 5.3% Apr 20, 2022
<ѻý>Who Is Really Driving Up Insulin Costs?ѻý> More attention needs to focus on pharmaceutical middlemen Apr 18, 2022
<ѻý>In Type 2 Diabetes, Metabolic Control Could Add Years to Lifeѻý> Controlling four biomarkers could add as much as a decade to life expectancy Apr 18, 2022
<ѻý>The Winners and Losers of the Proposed Insulin Cost Capѻý> While it benefits some, the $35 cap is only a stopgap measure Apr 08, 2022
<ѻý>Which Anticonvulsant Mood Stabilizer Upped Diabetes Risk?ѻý> Observational study looked at 5-year risk differences between four agents Apr 06, 2022
<ѻý>Cannabis-Exposed Babies Face Poorer Metabolic Healthѻý> By age 5, fat mass and glucose levels show the impact Mar 31, 2022
<ѻý>GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder?ѻý> Link with gallbladder, biliary diseases could be due to weight loss associated with class of drug Mar 28, 2022
<ѻý>Artificial Sweeteners Not So Sweet When It Comes to Cancer Riskѻý> Consumption of certain sugar alternatives linked to a 13% higher risk of developing cancer Mar 24, 2022
<ѻý>E-Cig Use Tied to Higher Odds of Prediabetesѻý> As in regular cigarettes, nicotine may play a role, researcher says Mar 03, 2022
<ѻý>Gestational Diabetes Risk Higher After Previous Miscarriageѻý> Risk increased with each prior spontaneous abortion Mar 03, 2022
<ѻý>Gastric Bypass Most Cost-Effective for Severe Obesity, T2D?ѻý> Modeling study compares Roux-en-Y, conventional medical therapy, and sleeve gastrectomy Feb 14, 2022
<ѻý>FDA OKs 180-Day Implantable Continuous Glucose Monitorѻý> Senseonics' Eversense E3 System approved for adults with diabetes Feb 11, 2022
<ѻý>Novel Tirzepatide Wins as Insulin Glargine Add-Onѻý> Another trial in the SURPASS clinical program met primary endpoint Feb 08, 2022
<ѻý>Gestational Diabetes Tied to Long-Term Cardiovascular Risksѻý> Chronic comorbidities partly explain risk, researcher says Feb 04, 2022
<ѻý>Warning Labels on Sugary Drinks: Do They Work?ѻý> Randomized trial found picture warning labels turned parents off Feb 01, 2022
<ѻý>Obesity More Common in Type 1 Diabetes Than Expectedѻý> And this is putting the population at a higher risk for chronic kidney disease, researchers say Jan 26, 2022
<ѻý>False Positive COVID Tests; Cannabis and Car Accidentsѻý> Also in TTHealthWatch: diabetes risk among kids with COVID Jan 15, 2022 podcast
<ѻý>Semaglutide vs Liraglutide -- Which Induces More Weight Loss?ѻý> The GLP-1 receptor agonists go head-to-head Jan 11, 2022
<ѻý>Weight-Loss Drug Wegovy Exceeded Expectations, and Supplyѻý> Since its June approval, the injectable flew off shelves and into short supply Dec 29, 2021
<ѻý>Use of GLP-1 Receptor Agonists Scarce in Type 2 Diabetesѻý> Particularly so for racial/ethnic minority populations Dec 17, 2021
<ѻý>Wide Racial Gap for Diabetes Tech Use Among Medicare Patientsѻý> Insulin pump and CGM use significantly lower among black patients Dec 15, 2021
<ѻý>Digital HTN, Diabetes Monitoring Program a Boon for Patientsѻý> Program reports growth and better outcomes Dec 09, 2021
<ѻý>Type 1 vs Type 2 Youth-Onset Diabetes: Which Is Worse for the Eyes?ѻý> One type had a higher risk for all diabetes-related ocular complications Dec 02, 2021
<ѻý>Another Study Confirms Gout Benefit With SGLT2 Inhibitorsѻý> Gout risk reduction was significantly better than with DPP-4 inhibitors Nov 19, 2021
<ѻý>Weight Loss Win for Weekly Injections of Novel Amylin Agent in Early Trialѻý> Cagrilintide at least on par with liraglutide after 26 weeks Nov 18, 2021
<ѻý>Blood-Based Biomarkers Prove Mettle in Liver Disease Diagnosisѻý> Data part of initiative to qualify biomarkers to help diagnose fibrosis or NASH Nov 15, 2021